Dear Sir/Madam, Please find attached the certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants), Regulations, 2018 issued ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has submitted a routine compliance certificate to BSE and MSEI, issued by its Registrar and Share Transfer Agent (RTA) Purva Sharegistry (India) Pvt. Ltd, for the quarter ended 30 September 2025. The certificate confirms that any share certificates received from depository participants for dematerialization during the quarter were processed, confirmed or rejected, and the names of depositories were substituted in the register of members within SEBI-prescribed timelines. The accompanying details table shows NIL activity across all columns — no certificates, no folio numbers, and no shares were dematerialized during 1 July to 30 September 2025. The filing was signed by Director Davender Singh (DIN: 09447213) and the RTA's Compliance Officer Ms. Deepali Dhuri.
This is a standard, routine regulatory compliance filing with no business or financial impact. With zero dematerialization activity in the quarter, there is no change in shareholding structure, no material event for investors, and no expected movement in the stock price.